William J Chase Receives Stock Award at Intellia Therapeutics Inc (NTLA) — SEC Form 4, Jun 13, 2025

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

William J Chase

Director

TXN 2025-06-11 · FILED 2025-06-13

Equity Position 34.7K sh 26,693 → 34,693

Equity Change +30.0% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Intellia Therapeutics Inc

NTLA CIK 0001652130

Reporting Owner

Name	Relationship
William J Chase CIK 0001563572	Director

William J Chase at Intellia Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Intellia Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2025-06-11	A - Award/Grant	8,000 A	$0.00	—	34,693	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (right to buy)F2	$8.37	2025-06-11	A - Award/Grant	11,450 A	$0.00	2035-06-10	11,450 Common Stock	Direct

Footnotes (2)

F1: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. Show more
F2: This option was granted on June 11, 2025 with respect to 11,450 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant. Show more